Joleen M. Hubbard
Allina Health(US)Mayo Clinic in Arizona(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Genetic factors in colorectal cancer, Colorectal and Anal Carcinomas, Cancer Genomics and Diagnostics
Most-Cited Works
- → Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology(2021)1,707 cited
- → Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)781 cited
- → NCCN Guidelines Insights: Rectal Cancer, Version 6.2020(2020)490 cited
- → Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years(2017)438 cited
- → Non-V600BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer(2017)354 cited
- → Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology(2019)255 cited
- → Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial(2022)228 cited
- → Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study(2023)227 cited
- → Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report(2021)210 cited
- → Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas(2017)189 cited